Purple Biotech (PPBT) Cash & Equivalents (2014 - 2026)
Purple Biotech (PPBT) posted Cash & Equivalents of $5.24 million for Q2 2026, up 10.6% from $4.74 million a year earlier but down 5.9% from the prior quarter.
Powered by 
Analysis
Purple Biotech (PPBT) Cash & Equivalents (2014 - 2026) Analysis & Trends
At the end of FY2025, Purple Biotech's Cash & Equivalents came in at $8.72 million, up 17.8% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -5.0% (FY2020 to FY2025).
- In prior years, Purple Biotech's Cash & Equivalents was $7.4 million in FY2024 (-50.8%), $15.03 million in FY2023 (unchanged), $15.03 million in FY2022 (+33.6%) and $11.25 million in FY2021 (unchanged).
- Quarterly Cash & Equivalents has run from a low of $4.74 million in Q2 2025 to a high of $23.54 million in Q1 2022 over five years.
- On a year-over-year basis, Cash & Equivalents increased in three of the last eight quarters, with an average decline of 10.2%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q1 2022, with growth of 130.9%; the weakest was Q3 2024, with a decline of 64.0%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $5.57 million (Q1 2026), $8.72 million (Q4 2025) and $9.59 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Purple Biotech | 249,214.64 | 191,214.64 | - | 5.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.24 Mn |
| Mar 31, 2026 | 5.57 Mn |
| Dec 31, 2025 | 8.72 Mn |
| Sep 30, 2025 | 9.59 Mn |
| Jun 30, 2025 | 4.74 Mn |
| Mar 31, 2025 | 5.77 Mn |
| Dec 31, 2024 | 7.40 Mn |
| Sep 30, 2024 | 5.44 Mn |
| Jun 30, 2024 | 6.52 Mn |
| Mar 31, 2024 | 9.99 Mn |
| Dec 31, 2023 | 14.49 Mn |
| Sep 30, 2023 | 15.10 Mn |
| Jun 30, 2023 | 17.20 Mn |
| Mar 31, 2023 | 21.88 Mn |
| Dec 31, 2022 | 15.03 Mn |
| Sep 30, 2022 | 11.07 Mn |
| Jun 30, 2022 | 14.01 Mn |
| Mar 31, 2022 | 23.54 Mn |
| Dec 31, 2021 | 10.89 Mn |
| Sep 30, 2021 | 9.12 Mn |
API Access
Purple Biotech Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PPBT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PPBT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PPBT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();